Novartis researchers have discovered a compound that is showing promise against three parasites that cause three neglected diseases.

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Advanced Accelerator Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.

University students majoring in the life sciences or business often have trouble imagining the direction of their careers.

On Friday nights, Juan Pedro García Hernández goes dancing – but for rest of the time he’s taking care of his mother.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Van der Kamp explains how leading by example has encouraged others to adopt flexible working models.

Gschwentner and Lackner discuss the advantages of their job share.

The culture of volunteerism is a fundamental part of the Novartis corporate ethos. Here’s a snapshot of our efforts over the years.